Muscle-specific Pparg deletion causes insulin resistance
about
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerAn oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesionPPARdelta regulates glucose metabolism and insulin sensitivitySmad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat dietSMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasisGlutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cellsNuclear receptor corepressors and PPARgammaIs the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?Hydroxycinnamic acid derivatives: a potential class of natural compounds for the management of lipid metabolism and obesityOrphan nuclear receptors and the regulation of nutrient metabolism: understanding obesityRoad to exercise mimetics: targeting nuclear receptors in skeletal musclePPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertaintyCommonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic StudiesEndocrinization of FGF1 produces a neomorphic and potent insulin sensitizerThe PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese ratsNovel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetesMusclin, a novel skeletal muscle-derived secretory factorIKK-beta links inflammation to obesity-induced insulin resistancePPARs and the complex journey to obesityDelivery of adiponectin gene to skeletal muscle using ultrasound targeted microbubbles improves insulin sensitivity and whole body glucose homeostasisMeta-analysis discovery of tissue-specific DNA sequence motifs from mammalian gene expression dataPPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance.Skeletal Muscle Nucleo-Mitochondrial Crosstalk in Obesity and Type 2 Diabetes.Women have higher protein content of beta-oxidation enzymes in skeletal muscle than men.Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice.Nuclear receptors, mitochondria and lipid metabolismMinireview: Pathophysiological roles of the TR4 nuclear receptor: lessons learned from mice lacking TR4Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator.Role of Nuclear Receptors in Exercise-Induced Muscle Adaptations.Peroxisome proliferator-activated receptor delta regulates mitofusin 2 expression in the heart.Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart.Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice.Differential Expression of PPARγ, FASN, and ACADM Genes in Various Adipose Tissues and Longissimus dorsi Muscle from Yanbian Yellow Cattle and Yan Yellow Cattle.Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-deficient miceRare mutations of peroxisome proliferator-activated receptor gamma: frequencies and relationship with insulin resistance and diabetes risk in the mixed ancestry population from South Africa.Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism.Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harmHigh-fat and obesogenic diets: current and future strategies to fight obesity and diabetes.
P2860
Q21328702-94930AF4-BD1A-4A35-9447-27875F5A1A7FQ24300694-9B8CAB02-8FAC-4C46-B6E2-A65D38231AE2Q24541495-2B6974F8-FE10-454B-91E1-A18F334A325EQ24633409-060B01AB-8D97-4A6D-8BE5-893A59C9DCE3Q24647529-3EA752D4-F680-4CA2-8DEE-C5BC43C809D0Q24655291-837EB5AA-66AF-4EAD-BA3E-C0FAF46A8857Q25257827-2B04BF4B-B5B9-4FF7-B876-7E3F698A6B1AQ26739984-08B2A628-0114-4BA8-95BF-3650E3F6F06FQ26749072-618E3343-9AE8-49C2-97F7-1F88863A092FQ26823819-C1D96E78-A0BA-4866-9452-4090E796C6EDQ26825855-8ABF8485-C5A7-495C-AE6D-EAEDB7FF2E5EQ27024799-F7BB4BB7-2704-4146-8374-6B3DAAE07EA0Q28070220-C54D1233-4AC3-42D1-B94B-B187FDE9B14CQ28221639-A798C8B6-2707-4BFB-AB57-64B4AF41639FQ28244332-E13E96B5-B9B5-44B3-9267-907C39BAE7AEQ28574993-919AB0A5-9871-4CDC-B5CF-C89D2581E9B0Q28583617-E7E2DA33-E467-4019-971F-4727CA65724FQ28585414-94BED5A5-629F-493F-98DE-8CE0E8CAFABAQ29614285-CDFB19C6-C8C5-4211-9591-9F6CB565C883Q29619271-8A2031FB-A867-42CE-A226-AB5FCBEAB9E7Q30444363-2196E7F5-A24C-41CF-B984-5634CE32D884Q31038373-E4EB360C-5AD9-4BE9-8EA9-3BAD82FE4FAEQ33283063-58B6C51B-BE38-4F40-9806-0CB9A11C44F2Q33581151-69DA84A8-2F4E-4A04-862B-6BB83A7EA75BQ33624769-DAC20A5C-2BD1-46DD-B3ED-4F3A44866A68Q33654084-C5345D0E-583D-4D79-BC88-0D1928EFEB9FQ33655519-C94090CD-2BF6-40DE-9013-D6B6A3AA2CE5Q33699001-E23CF856-C298-404F-A36D-53A650A5E5E0Q33701419-3C4D45FC-F7CC-4D4A-99A4-25F53FDE424EQ33736617-F672F0C1-A32F-4508-8A68-B0E525BA8694Q33751474-27033BF4-67AE-44DF-860A-57B7DCD43463Q33752733-98B8524E-AE9B-4194-9C87-BC49AC71310FQ33819755-602FB75C-422A-45A6-BF44-4DB5F9AA510CQ33832505-A8818D12-BD88-4E48-862F-4C929B6D7F9BQ33885474-7ECE3646-0DE9-4921-B617-3B1DD806A91BQ33957864-745C5E46-8057-4DB7-B88D-42C7CD07E3FBQ34114146-E7FCC743-FB02-45E0-B461-BBEBB30D36B0Q34150535-88D79053-02A6-4A78-8428-604CE2AF87E3Q34165847-125F2E11-F0CD-4FA6-AF63-EA94264F6065Q34212924-1B184886-DE4E-44E4-A1CA-B7E0170B3AC0
P2860
Muscle-specific Pparg deletion causes insulin resistance
description
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Dezember 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/12/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/12/01)
@nl
наукова стаття, опублікована в грудні 2003
@uk
مقالة علمية (نشرت في ديسمبر 2003)
@ar
name
Muscle-specific Pparg deletion causes insulin resistance
@ast
Muscle-specific Pparg deletion causes insulin resistance
@en
Muscle-specific Pparg deletion causes insulin resistance
@nl
type
label
Muscle-specific Pparg deletion causes insulin resistance
@ast
Muscle-specific Pparg deletion causes insulin resistance
@en
Muscle-specific Pparg deletion causes insulin resistance
@nl
prefLabel
Muscle-specific Pparg deletion causes insulin resistance
@ast
Muscle-specific Pparg deletion causes insulin resistance
@en
Muscle-specific Pparg deletion causes insulin resistance
@nl
P2093
P3181
P356
P1433
P1476
Muscle-specific Pparg deletion causes insulin resistance
@en
P2093
Andrea L. Hevener
Gautam Bandyopadhyay
Jason Wilkes
Peter Olson
Yaacov Barak
P2888
P304
P3181
P356
10.1038/NM956
P407
P577
2003-12-01T00:00:00Z